Next Article in Journal
Integrating Primary Care Providers through the Seasons of Survivorship
Previous Article in Journal
A Case of Nivolumab-Induced Acute-Onset Type 1 Diabetes Mellitus in Melanoma
 
 

Order Article Reprints

Journal: Curr. Oncol., 2019
Volume: 26
Number: 4809

Article: Brigatinib is another treatment option for patients diagnosed with advanced ALK-positive non-small-cell lung cancer who are treatment-naïve or who have progressed on or are intolerant to crizotinib
Authors: by Barbara Melosky, Parneet Cheema and Geoffrey Liu
Link: https://www.mdpi.com/1718-7729/26/1/4809

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Shipping Address

Billing Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop